Table 4.
Comparison of laboratory abnormalities and complications between the survival and non-survival group (n = 35)
| Survived | Died | ||
|---|---|---|---|
| (n = 25) | (n = 10) | P-value | |
| Anaemia, n (%) | 24 (96) | 10 (100) | 1.000a |
| Leucocytosis, n (%) | 11 (60.2) | 8 (80) | 0.071a |
| Hyperkalaemia, n (%) | 16 (64) | 8 (80) | 0.447a |
| Metabolic acidosis, n (%) | 9 (37.5) | 9 (90) | 0.458a |
| Haemolysis, n (%) | 23 (92) | 9 (90) | 1.000a |
| Rhabdomyolysis, n (%) | 15 (60) | 7 (70) | 0.709a |
| Hepatic dysfunction, n (%) | 18 (72) | 8 (80) | 1.000a |
| ARDS, n (%) | 0 (0) | 4 (40) | 0.004a |
| Encephalopathy, n (%) | 0 (0) | 4 (40) | 0.004a |
| Dialysis, n (%) | 20 (80) | 9 (90) | 0.649a |
a
Chi-square with Fisher’s exact test.